Delivery Order SPE2DB20D1109-SPE2DB25FP18W
Award Date
6/5/25
Potential Completion Date
6/6/25
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,011.70 firm fixed-price delivery order is for the supply of 24,000 units of the prescription medication PERTZYE DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $7,961.40, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 24,000 units of the pharmaceutical product PERTZYE DR 24,000 UNIT CAPSULE UU 80S. This delivery order contract, with a final completion date of October 9, 2024, is a firm-fixed-price contract. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical supplies and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 unit capsules of the drug Pertzye, with a ceiling value of $9,416.10 and a completion date of February 5, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,179.36 firm fixed price delivery order (SPE2DB20D3101|SPE2DB24FRBB8) is for the supply of 16,000 units of PERTZYE DR 100S capsules. The contract has a completion date of February 9, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 16,000 units of the pharmaceutical product Pertzye DR Capsule, with a total ceiling value of $23,802.53. The delivery order has a firm fixed price pricing type and is set to be completed by February 9, 2024. This award is not designated with any set-aside requirements, indicating full and open...
This contract award with ID SPE2DX15D1022|SPE2DX24FVEXG was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The firm fixed price delivery order, valued at $6,810.91, is for the supply of 24,000 units of the prescription drug PERTZYE DR 24,000 UNIT CAPSULE. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $21,832.50 firm-fixed-price delivery order is for the supply of 16,000 units of the PERTZYE DR 250S capsule product. The contract has an ultimate completion date of August 28, 2024. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $9,532.40, is a delivery order with a firm fixed price pricing type and an ultimate completion date of April 11, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $8,053.49 firm fixed price delivery order contract has an ultimate completion date of May 8, 2025 and is not set aside. It is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...